An Open Label, Pharmacokinetic Study of Single and Multiple Doses of 5 mg Saxagliptin in Healthy Chinese Subjects Living in China.
Phase of Trial: Phase I
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 10 Jul 2009 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 10 Jul 2009 Actual patient number (34) added as reported by ClinicalTrials.gov.
- 10 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.